Atomistry » Fluorine » PDB 4zzj-5ah8 » 5a14
Atomistry »
  Fluorine »
    PDB 4zzj-5ah8 »
      5a14 »

Fluorine in PDB 5a14: Human CDK2 with Type II Inhibitor

Enzymatic activity of Human CDK2 with Type II Inhibitor

All present enzymatic activity of Human CDK2 with Type II Inhibitor:
2.7.11.1; 2.7.11.22;

Protein crystallography data

The structure of Human CDK2 with Type II Inhibitor, PDB code: 5a14 was solved by L.T.Alexander, J.M.Elkins, J.Kopec, O.Fedorov, P.A.Savitsky, H.Moebitz, S.W.Cowan-Jacob, M.Szklarz, A.C.W.Pike, E.P.Carpenter, T.Krojer, C.Bountra, A.M.Edwards, S.Knapp, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 53.69 / 2.00
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 64.410, 67.270, 89.130, 90.00, 90.00, 90.00
R / Rfree (%) 19.4 / 24

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Human CDK2 with Type II Inhibitor (pdb code 5a14). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total 6 binding sites of Fluorine where determined in the Human CDK2 with Type II Inhibitor, PDB code: 5a14:
Jump to Fluorine binding site number: 1; 2; 3; 4; 5; 6;

Fluorine binding site 1 out of 6 in 5a14

Go back to Fluorine Binding Sites List in 5a14
Fluorine binding site 1 out of 6 in the Human CDK2 with Type II Inhibitor


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Human CDK2 with Type II Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F1297

b:36.9
occ:1.00
F26 A:LQ51297 0.0 36.9 1.0
C25 A:LQ51297 1.4 35.5 1.0
F28 A:LQ51297 2.1 34.2 1.0
F27 A:LQ51297 2.2 36.9 1.0
C24 A:LQ51297 2.4 33.4 1.0
C23 A:LQ51297 3.1 32.0 1.0
CD2 A:HIS125 3.1 32.4 1.0
C30 A:LQ51297 3.2 33.0 1.0
C29 A:LQ51297 3.4 31.4 1.0
NE2 A:HIS125 3.5 31.9 1.0
O A:ALA144 3.9 27.9 1.0
C A:ALA144 3.9 29.3 1.0
C32 A:LQ51297 3.9 34.2 1.0
N31 A:LQ51297 4.1 35.4 1.0
N A:ASP145 4.2 30.8 1.0
CG A:HIS125 4.3 31.1 1.0
CA A:ALA144 4.3 28.9 1.0
CB A:ASP145 4.3 34.8 1.0
CB A:LEU143 4.4 29.2 1.0
N A:ALA144 4.4 28.3 1.0
C22 A:LQ51297 4.4 31.6 1.0
C A:LEU143 4.5 28.3 1.0
C20 A:LQ51297 4.6 32.9 1.0
CE1 A:HIS125 4.6 32.5 1.0
O A:LEU143 4.8 29.2 1.0
CA A:ASP145 4.9 33.4 1.0

Fluorine binding site 2 out of 6 in 5a14

Go back to Fluorine Binding Sites List in 5a14
Fluorine binding site 2 out of 6 in the Human CDK2 with Type II Inhibitor


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 2 of Human CDK2 with Type II Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F1297

b:36.9
occ:1.00
F27 A:LQ51297 0.0 36.9 1.0
C25 A:LQ51297 1.4 35.5 1.0
F28 A:LQ51297 2.2 34.2 1.0
F26 A:LQ51297 2.2 36.9 1.0
C24 A:LQ51297 2.4 33.4 1.0
C23 A:LQ51297 3.0 32.0 1.0
C30 A:LQ51297 3.0 33.0 1.0
C29 A:LQ51297 3.5 31.4 1.0
CD1 A:LEU58 3.5 32.6 1.0
CG2 A:ILE63 3.7 31.7 1.0
C22 A:LQ51297 4.3 31.6 1.0
N31 A:LQ51297 4.4 35.4 1.0
CB A:LEU58 4.6 32.8 1.0
CD1 A:ILE63 4.7 36.6 1.0
C20 A:LQ51297 4.7 32.9 1.0
SG A:CYS118 4.7 32.9 1.0
CG A:LEU58 4.7 32.7 1.0
C32 A:LQ51297 4.9 34.2 1.0

Fluorine binding site 3 out of 6 in 5a14

Go back to Fluorine Binding Sites List in 5a14
Fluorine binding site 3 out of 6 in the Human CDK2 with Type II Inhibitor


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 3 of Human CDK2 with Type II Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F1297

b:34.2
occ:1.00
F28 A:LQ51297 0.0 34.2 1.0
C25 A:LQ51297 1.3 35.5 1.0
F26 A:LQ51297 2.1 36.9 1.0
F27 A:LQ51297 2.2 36.9 1.0
C24 A:LQ51297 2.4 33.4 1.0
C29 A:LQ51297 2.8 31.4 1.0
O A:LEU143 3.2 29.2 1.0
CA A:ALA144 3.4 28.9 1.0
C A:LEU143 3.5 28.3 1.0
CG2 A:ILE63 3.6 31.7 1.0
N A:ALA144 3.7 28.3 1.0
C23 A:LQ51297 3.7 32.0 1.0
C A:ALA144 3.8 29.3 1.0
CG1 A:VAL64 4.0 30.6 1.0
CB A:LEU143 4.1 29.2 1.0
N A:ASP145 4.2 30.8 1.0
C20 A:LQ51297 4.2 32.9 1.0
O A:ALA144 4.3 27.9 1.0
O39 A:LQ51297 4.3 29.7 1.0
C30 A:LQ51297 4.4 33.0 1.0
CA A:LEU143 4.5 28.3 1.0
N A:VAL64 4.7 29.9 1.0
CB A:ALA144 4.7 30.3 1.0
CB A:ILE63 4.8 31.9 1.0
CD2 A:LEU55 4.8 33.5 1.0
C22 A:LQ51297 4.9 31.6 1.0
CD2 A:HIS125 5.0 32.4 1.0

Fluorine binding site 4 out of 6 in 5a14

Go back to Fluorine Binding Sites List in 5a14
Fluorine binding site 4 out of 6 in the Human CDK2 with Type II Inhibitor


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 4 of Human CDK2 with Type II Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F1298

b:44.7
occ:1.00
F26 A:LQ51298 0.0 44.7 1.0
C25 A:LQ51298 1.4 44.7 1.0
F28 A:LQ51298 2.2 42.8 1.0
F27 A:LQ51298 2.2 49.6 1.0
C24 A:LQ51298 2.5 42.4 1.0
C29 A:LQ51298 2.8 38.2 1.0
C23 A:LQ51298 3.8 41.7 1.0
CE2 A:PHE213 4.1 35.5 1.0
C20 A:LQ51298 4.2 39.4 1.0
O39 A:LQ51298 4.4 38.8 1.0
CD2 A:PHE213 4.5 34.2 1.0
C30 A:LQ51298 4.5 41.5 1.0
C22 A:LQ51298 4.9 40.9 1.0

Fluorine binding site 5 out of 6 in 5a14

Go back to Fluorine Binding Sites List in 5a14
Fluorine binding site 5 out of 6 in the Human CDK2 with Type II Inhibitor


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 5 of Human CDK2 with Type II Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F1298

b:49.6
occ:1.00
F27 A:LQ51298 0.0 49.6 1.0
C25 A:LQ51298 1.4 44.7 1.0
F26 A:LQ51298 2.2 44.7 1.0
F28 A:LQ51298 2.2 42.8 1.0
C24 A:LQ51298 2.4 42.4 1.0
C23 A:LQ51298 3.1 41.7 1.0
C30 A:LQ51298 3.1 41.5 1.0
C29 A:LQ51298 3.6 38.2 1.0
N31 A:LQ51298 4.4 42.9 1.0
C22 A:LQ51298 4.4 40.9 1.0
C32 A:LQ51298 4.7 42.5 1.0
C20 A:LQ51298 4.8 39.4 1.0

Fluorine binding site 6 out of 6 in 5a14

Go back to Fluorine Binding Sites List in 5a14
Fluorine binding site 6 out of 6 in the Human CDK2 with Type II Inhibitor


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 6 of Human CDK2 with Type II Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F1298

b:42.8
occ:1.00
F28 A:LQ51298 0.0 42.8 1.0
C25 A:LQ51298 1.4 44.7 1.0
F26 A:LQ51298 2.2 44.7 1.0
F27 A:LQ51298 2.2 49.6 1.0
C24 A:LQ51298 2.3 42.4 1.0
C23 A:LQ51298 3.1 41.7 1.0
C30 A:LQ51298 3.2 41.5 1.0
C29 A:LQ51298 3.4 38.2 1.0
C32 A:LQ51298 3.6 42.5 1.0
CH2 A:TRP243 4.0 40.3 1.0
N31 A:LQ51298 4.0 42.9 1.0
CZ2 A:TRP243 4.0 41.4 1.0
CB A:PRO241 4.2 40.0 1.0
C22 A:LQ51298 4.3 40.9 1.0
C20 A:LQ51298 4.6 39.4 1.0
CG A:PRO241 4.6 38.7 1.0
CD2 A:PHE213 4.8 34.2 1.0
CE2 A:PHE213 4.9 35.5 1.0
C21 A:LQ51298 5.0 37.6 1.0

Reference:

L.T.Alexander, H.Mobitz, P.Drueckes, P.Savitsky, O.Fedorov, J.M.Elkins, C.M.Deane, S.W.Cowan-Jacob, S.Knapp. Type II Inhibitors Targeting CDK2. Acs Chem.Biol. V. 10 2116 2015.
ISSN: ISSN 1554-8929
PubMed: 26158339
DOI: 10.1021/ACSCHEMBIO.5B00398
Page generated: Sun Dec 13 12:17:49 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy